ISSN: 1472-8222

Journal Home

Journal Guideline

Expert Opinion on Therapeutic Targets Q1 Unclaimed

Taylor and Francis Ltd. United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Expert Opinion on Therapeutic Targets is a journal indexed in SJR in Drug Discovery and Pharmacology with an H index of 106. It has a price of 4000 €. It has an SJR impact factor of 1,423 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,423.

Expert Opinion on Therapeutic Targets focuses its scope in these topics and keywords: target, therapeutic, potential, receptor, histone, immunotherapy, leukemiaanaplastic, lymphoma, illnessis, methylationnf?b, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Clinical Biochemistry (Q1) Drug Discovery (Q1) Molecular Medicine (Q1) Pharmacology (Q1)

Price

4000 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

1,423

SJR Impact factor

106

H Index

103

Total Docs (Last Year)

274

Total Docs (3 years)

11531

Total Refs

1287

Total Cites (3 years)

245

Citable Docs (3 years)

3.99

Cites/Doc (2 years)

111.95

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Protein & Cell Q1
Molecular Therapy Q1
Nature Reviews Drug Discovery Q1
Medicinal Research Reviews Q1
Cell Chemical Biology Q1

Compare this journals

Aims and Scope

Best articles by citations

Modulation of apoptosis as a target for liver disease

Molecular targets in immune-mediated diseases: focus on rheumatoid arthritis

Oncogene-targeted antisense oligonucleotides for the treatment of Ewing sarcoma

Pyruvate dehydrogenase as a therapeutic target for obesity cardiomyopathy

Molecular targets in the inhibition of angiogenesis

TIPE2 as a potential therapeutic target in chronic viral hepatitis

The therapeutic potential of neuronal KCNQ channel modulators

Receptor tyrosine kinase-like orphan receptor 1: a novel target for cancer immunotherapy

The MAP kinase-interacting kinases (MNKs) as targets in oncology

Functional genetic evaluation of DNA house-cleaning enzymes in the malaria parasite: dUTPase and Ap4AH are essential in Plasmodium berghei but ITPase and NDH are dispensable

G-Protein-Coupled Receptors: New Approaches to Maximise the Impact of GPCRs in Drug Discovery

Superoxide dismutase: an emerging target for cancer therapeutics

SHOW MORE ARTICLES

An in-depth analysis shows a hidden atherogenic lipoprotein profile in non-diabetic chronic kidney disease patients

Histone deacetylase inhibitors: insights into mechanisms of lethality

The plastid-derived organelle ofprotozoan human parasites asa target of established and emerging drugs

Recent advances towards identification of new drug targets for Mycobacterium tuberculosis

Targeting the A2B adenosine receptor during gastrointestinal ischemia and inflammation

Mechanisms of MHC class I-restricted antigen presentation

Targeting the cell signaling pathway Keap1-Nrf2 as a therapeutic strategy for adenocarcinomas of the lung

Therapeutic targets for antimetastatic therapy

Targeted therapies for prostate cancer

Death associated protein kinase as a potential therapeutic target

New developments in the urokinase-type plasminogen activator system

Non-coding RNAs as direct and indirect modulators of epigenetic mechanism regulation of cardiac fibrosis